90 related articles for article (PubMed ID: 1334843)
1. Platelet receptor expression on three human megakaryoblast-like cell lines.
Vittet D; Mathieu MN; Launay JM; Chevillard C
Exp Hematol; 1992 Oct; 20(9):1129-34. PubMed ID: 1334843
[TBL] [Abstract][Full Text] [Related]
2. Thrombin inhibits proliferation of the human megakaryoblastic MEG-01 cell line: a possible involvement of a cyclic-AMP dependent mechanism.
Vittet D; Mathieu MN; Launay JM; Chevillard C
J Cell Physiol; 1992 Jan; 150(1):65-75. PubMed ID: 1309828
[TBL] [Abstract][Full Text] [Related]
3. Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells.
Feoktistov I; Murray JJ; Biaggioni I
Mol Pharmacol; 1994 Jun; 45(6):1160-7. PubMed ID: 8022409
[TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
Cheng L; Qasba P; Vanguri P; Thiede MA
J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
[TBL] [Abstract][Full Text] [Related]
5. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
6. [Expression of cyclin B in megakaryocytes and cells of other hematopoietic lines].
Gu XF; Allain A; Li L; Cramer EM; Tenza D; Caen JP; Han ZC
C R Acad Sci III; 1993 Dec; 316(12):1438-45. PubMed ID: 8087623
[TBL] [Abstract][Full Text] [Related]
7. Cyclic-AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell line.
Vittet D; Duperray C; Chevillard C
J Cell Physiol; 1995 Jun; 163(3):645-55. PubMed ID: 7539815
[TBL] [Abstract][Full Text] [Related]
8. Genetic manipulation of megakaryocytes to study platelet function.
Liu J; DeNofrio J; Yuan W; Wang Z; McFadden AW; Parise LV
Curr Top Dev Biol; 2008; 80():311-35. PubMed ID: 17950378
[TBL] [Abstract][Full Text] [Related]
9. A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells.
Gandhi MJ; Drachman JG; Reems JA; Thorning D; Lannutti BJ
Blood Cells Mol Dis; 2005; 35(1):70-3. PubMed ID: 15923131
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro.
Choi ES; Hokom M; Bartley T; Li YS; Ohashi H; Kato T; Nichol JL; Skrine J; Knudten A; Chen J
Stem Cells; 1995 May; 13(3):317-22. PubMed ID: 7542117
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
Steen VM; Holmsen H
Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
[TBL] [Abstract][Full Text] [Related]
12. Not Ca2+ but CAMP is the second messenger for morphological changes in rat megakaryocyte.
Uneyama C; Imazawa T; Uneyama H; Akaike N; Kawanishi T; Takahashi M
Biochem Biophys Res Commun; 1995 Jun; 211(1):282-8. PubMed ID: 7779097
[TBL] [Abstract][Full Text] [Related]
13. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
[TBL] [Abstract][Full Text] [Related]
14. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
15. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
16. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
17. Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function.
Soslau G; Morgan DA; Jaffe JS; Brodsky I; Wang Y
Cytokine; 1997 Jun; 9(6):405-11. PubMed ID: 9199874
[TBL] [Abstract][Full Text] [Related]
18. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of platelet activation and inhibition.
Ashby B; Daniel JL; Smith JB
Hematol Oncol Clin North Am; 1990 Feb; 4(1):1-26. PubMed ID: 2155902
[TBL] [Abstract][Full Text] [Related]
20. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
